CXCL12
Also known as: SDF-1, stromal cell-derived factor 1, SDF-1alpha
CXCL12, also called SDF-1, is a chemokine, which is a small signaling protein that directs the movement of cells. It is the only known ligand of the CXCR4 receptor, and the CXCL12/CXCR4 pair plays a critical role in guiding immune cells, stem cells, and developing tissues. The pair is extensively studied in areas including stem cell homing, cancer microenvironments, fibrosis, and HIV research.
Quick Reference
CXCL12 - Research Images
PSO vial render · Scientific images from Wikipedia · Tap to enlarge
Overview
Mammalian protein found in Homo sapiens
The stromal cell-derived factor 1 (SDF-1), also known as C-X-C motif chemokine 12 (CXCL12), is a chemokine protein that in humans is encoded by the CXCL12 gene on chromosome 10. It is ubiquitously expressed in many tissues and cell types. Stromal cell-derived factors 1-alpha and 1-beta are small cytokines that belong to the chemokine family, members of which activate leukocytes and are often induced by proinflammatory stimuli such as lipopolysaccharide, TNF, or IL1. The chemokines are characterized by the presence of 4 conserved cysteines that form 2 disulfide bonds. They can be classified into 2 subfamilies. In the CC subfamily, the cysteine residues are adjacent to each other. In the CXC subfamily, they are separated by an intervening amino acid. The SDF1 proteins belong to the latter group. CXCL12 signaling has been observed in several cancers. The CXCL12 gene also contains one of 27 SNPs associated with increased risk of coronary artery disease.
Mechanism of Action
Cells expressing CXCR4 detect CXCL12 gradients and migrate toward higher concentrations. Activation of CXCR4 results in increased intracellular calcium and cell movement. The receptor ACKR3 also binds CXCL12 but acts as a scavenger without typical signaling, affecting the availability of CXCL12. This system retains stem cells in the bone marrow and can protect cancer cells within tumors by stromal cells secreting CXCL12, as described in recent studies.
Research History
CXCL12 was identified in the mid-1990s as a factor produced by bone-marrow stromal cells, which led to its alternate name, stromal cell-derived factor 1. The CXCR4 receptor gained prominence in 1996 when it was identified as a co-receptor that HIV uses to enter cells. Research has since explored their roles in embryonic development, marrow stem-cell retention, and, more recently, in tumors and fibrosis during the 2020s. Recent studies have detailed where CXCL12 is located within tumors and aging tissues.
What Researchers Are Saying
Community Reports - Not Medical Advice
The following is aggregated from public forums, Reddit, and research communities. These are anecdotal reports from researchers only - not verified clinical data and not a recommendation of any kind.
CXCL12 (also known as SDF-1, stromal cell-derived factor 1) is studied within the immune modulation research community. Chemokine that directs CXCR4-expressing cell homing studied in stem cell mobilization, tumor microenvironment, and HIV research.
Last updated October 28, 2026
Research status: active. CXCL12 appears across immune modulation research forums and academic literature. Researchers note this compound falls in the immune category.
Last updated October 28, 2026
What Do You Think of This Peptide?
Share your opinion or research experience with CXCL12. Comments are reviewed before appearing.